DDInter472 DDInter1082
A synthetic steroid with antigonadotropic and anti-estrogenic activities that acts as an anterior pituitary suppressant by inhibiting the pituitary output of gonadotropins. It possesses some androgenic properties. Danazol has been used in the treatment of endometriosis and some benign breast disorders.
Lixisenatide is a glucagon-like peptide-1 (GLP-1) receptor agonist used in the treatment of type II diabetes mellitus (T2DM). It is sold by Sanofi-Aventis under the brand name Adlyxin in the US and Lyxumia in the EU. Adlyxin recieved FDA approval July 28, 2016.
Danazol {u} (Compound) resembles {v} (Compound) Ethinylestradiol
Danazol {u} (Compound) resembles {v} (Compound) Oxandrolone
Danazol {u} (Compound) binds {v} (Gene) AR
Danazol {u} (Compound) upregulates {v} (Gene) TSKU
Danazol {u} (Compound) is included by {v} (Pharmacologic Class) Androstanes
Danazol {u} (Compound) downregulates {v} (Gene) TP53
Danazol {u} (Compound) causes {v} (Side Effect) Acne
Danazol {u} may cause a minor interaction that can limit clinical effects when taken with {v} Sibutramine
Danazol {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Miglitol
Danazol {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Cobimetinib
Danazol (Compound) resembles Ethinylestradiol (Compound)
Danazol (Compound) resembles Oxandrolone (Compound)
Danazol (Compound) binds AR (Gene)
Danazol (Compound) upregulates TSKU (Gene)
Danazol (Compound) is included by Androstanes (Pharmacologic Class)
Danazol (Compound) downregulates TP53 (Gene)
Danazol (Compound) causes Acne (Side Effect)
Danazol may cause a minor interaction that can limit clinical effects when taken with Sibutramine
Danazol may cause a moderate interaction that could exacerbate diseases when taken with Miglitol
Danazol may cause a moderate interaction that could exacerbate diseases when taken with Cobimetinib